References
- 1. Chiu C, Legrand M. Epidemiology of sepsis and septic shock. Curr Opin Anaesthesiol. 2021;34(2):71-6. DOI: 10.1097/ACO.0000000000000958
- 2. Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent JL. Biomarkers of sepsis: time for a reappraisal. Crit Care. 2020;24(1):287. DOI: 10.1186/s13054-020-02993-5
- 3. Tauber SC, Djukic M, Gossner J, Eiffert H, Brück W, Nau R. Sepsis-associated encephalopathy and septic encephalitis: an update. Expert Rev Anti Infect Ther. 2021;19(2):215-31. DOI: 10.1080/14787210.2020.1812384
- 4. Gao Q, Hernandes MS. Sepsis-Associated Encephalopathy and Blood-Brain Barrier Dysfunction. Inflammation. 2021;44(6):2143-50. DOI: 10.1007/s10753-021-01501-3
- 5. Chung HY, Wickel J, Brunkhorst FM, Geis C. Sepsis-Associated Encephalopathy: From Delirium to Dementia? J Clin Med. 2020;9(3):703. DOI: 10.3390/jcm9030703
- 6. Ren C, Yao RQ, Zhang H, Feng YW, Yao YM. Sepsis-associated encephalopathy: a vicious cycle of immunosuppression. J Neuroinflammation. 2020;17(1):14. DOI: 10.1186/s12974-020-1701-3
- 7. Ren C, Yao RQ, Zhang H, Feng YW, Yao YM. Pathogenesis of sepsis-associated encephalopathy: more than blood-brain barrier dysfunction. Mol Biol Rep. 2022;49(10):10091-9. DOI: 10.1007/s11033-022-07592-x
- 8. Society of Critical Care Medicine, Chinese Medical Association. Guidelines for the treatment of severe sepsis/septic shock in China (2014). Chin Crit Care Med. 2015;27:401-26. DOI: 10.3760/cma.j.issn.2095-4352.2015.06.001
- 9. Zhao L, Gao Y, Guo S, et al. Sepsis-Associated Encephalopathy: Insight into Injury and Pathogenesis. CNS Neurol Disord Drug Targets. 2021;20(2):112-24. DOI: 10.2174/18715273MTExrNTka3
- 10. Mazeraud A, Bozza FA, Sharshar T. Sepsis-associated Encephalopathy Is Septic. Am J Respir Crit Care Med. 2018;197(2):698-9. DOI: 10.1164/rccm.201712-2593ED
- 11. Wei XB, Jiang WQ, Zeng JH, Huang LQ, Ding HG, Jing YW, et al. Exosome-Derived lncRNA NEAT1 Exacerbates Sepsis-Associated Encephalopathy by Promoting Ferroptosis Through Regulating miR-9-5p/TFRC and GOT1 Axis. Mol Neurobiol. 2022;59(3):1954-69. DOI: 10.1007/s12035-022-02738-1
- 12. Kikuchi DS, Campos ACP, Qu H, Forrester SJ, Pagano RL, Lassègue B, et al. Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy. J Neuroinflammation. 2019;16(1):241. DOI: 10.1186/s12974-019-1575-4
- 13. Wu L, Ai ML, Feng Q, Deng S, Liu ZY, Zhang LN, et al. Serum glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 for diagnosis of sepsis-associated encephalopathy and outcome prognostication. J Crit Care. 2019,52:172-9. DOI: 10.1016/j.jcrc.2019.04.018
- 14. Liu X, Wen M, Han Y, Ding H, Chen S, Li Y, et al. Mechanism of resveratrol on ameliorating the cognitive dysfunction induced by sepsis associated encephalopathy in rats. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020;32(10):1189-93. DOI: 10.3760/cma.j.cn121430-20200720-00531
- 15. Yan S, Gao M, Chen H, Jin X, Yang M. Expression level of glial fibrillary acidic protein and its clinical significance in patients with sepsis-associated encephalopathy. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019;44(10):1137-42. DOI: 10.11817/j.issn.1672-7347.2019.190180
- 16. Li XL, Xie JF, Ye XY, Li Y, Li YG, Feng K, et al. Value of cerebral hypoxic-ischemic injury markers in the early diagnosis of sepsis associated encephalopathy in burn patients with sepsis. Zhonghua Shao Shang Za Zhi. 2022;38(1):21-8. DOI: 10.3760/cma.j.cn501120-20211006-00346
- 17. Zheng SM, Zhao FL, Luo YY, Lin XF, Wen MY. Clinical effect of electroacupuncture at Baihui and Shuigou points in treatment of brain injury in patients with sepsis-associated encephalopathy. Zhen Ci Yan Jiu. 2020;45(5):402-6. DOI: 10.13702/j.1000-0607.190781
- 18. Meng JF, Li YP, Tan DM, Chen MJ, Chen J. [Diagnosis value of combined detection of serum TNF-α, NSE and MCP-1 in early sepsis-related encephalopathy]. Hebei Medicine. 2020;26(10):1596-600.
- 19. Guo W, Li Y, Li Q. Relationship between miR-29a levels in the peripheral blood and sepsis-related encephalopathy. Am J Transl Res. 2021;13(7):7715-22.
- 20. Ehler J, Saller T, Wittstock M, Rommer PS, Chappell D, Zwissler B, et al. Diagnostic value of NT-proCNP compared to NSE and S100B in cerebrospinal fluid and plasma of patients with sepsis-associated encephalopathy. Neurosci Lett. 2019;692:167-73.. DOI: 10.1016/j.neulet.2018.11.014
- 21. Wu L, Feng Q, Ai ML, Deng SY, Liu ZY, Huang L, et al. The dynamic change of serum S100B levels from day 1 to day 3 is more associated with sepsis-associated encephalopathy. Sci Rep. 2020;10(1):7718. DOI: 10.1038/s41598-020-64200-3